Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Outperform on VF, Maintains $36 Price Target By Benzinga Newsdesk March 20, 5:16 AM Telsey Advisory Group analyst Dana Telsey reiterates VF (NYSE:VFC) with a Outperform and maintains $36 price target. VFC
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Acer Therapeutics, Maintains $7 Price Target By Benzinga Newsdesk March 20, 4:32 AM EF Hutton analyst Constantine Davides reiterates Acer Therapeutics (NASDAQ:ACER) with a Buy and maintains $7 price target. ACER
Read More 2 minute read Analyst Color Analyst Ratings News Penny Stocks Price Target Reiteration Tech Blend Labs Is Capable Of Rebound Over Time, Analyst Says Post Q4 Miss By Anusuya Lahiri March 17, 2:41 PM Canaccord Genuity analyst Joseph Vafi maintains Blend Labs Inc (NYSE: BLND) with a Hold, BLND
Read More 2 minute read Analyst Color Analyst Ratings General News Price Target Reiteration Small Cap Designer Brands’ H1 To Be Pressured Before Recovering In H2, Analyst Says By Shivani Kumaresan March 17, 2:25 PM Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating on the shares of Designer Brands Inc (NYSE:DBI) with a price… DBI
Read More 1 minute read Analyst Ratings News Price Target Reiteration Tech KVH Industries Q4 Gets Boost From Airtime Revenue, India Expansion Serving As Additional Catalyst: Analyst By Anusuya Lahiri March 17, 1:49 PM Needham analyst Ryan Koontz maintained a Buy rating on KVH Industries, Inc (NASDAQ:KVHI) with a price target of $13.00. KVHI reported 4Q22… KVHI
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target By Benzinga Newsdesk March 17, 11:27 AM HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and maintains $9 price target. IPA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Buy on Arcus Biosciences, Maintains $51 Price Target By Benzinga Newsdesk March 17, 9:12 AM Mizuho analyst Mara Goldstein reiterates Arcus Biosciences (NYSE:RCUS) with a Buy and maintains $51 price target. RCUS
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Buy on Sarepta Therapeutics, Maintains $160 Price Target By Benzinga Newsdesk March 17, 9:10 AM Mizuho analyst Uy Ear reiterates Sarepta Therapeutics (NASDAQ:SRPT) with a Buy and maintains $160 price target. SRPT
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on NCR, Maintains $32 Price Target By Benzinga Newsdesk March 17, 9:02 AM RBC Capital analyst Daniel Perlin reiterates NCR (NYSE:NCR) with a Outperform and maintains $32 price target. NCR
Read More 1 minute read Analyst Ratings News Price Target Reiteration Stephens & Co. Reiterates Overweight on Lifecore Biomedical, Maintains $11 Price Target By Benzinga Newsdesk March 17, 8:46 AM Stephens & Co. analyst Jacob Johnson reiterates Lifecore Biomedical (NASDAQ:LFCR) with a Overweight and maintains $11 price target. LFCR